Cohen JV, Liu M, Rogers G, Manos M, et al. Brief Communication: Personalized Circulating Tumor DNA as a Predictor of Pathologic Response in Neoadjuvant Treatment of Resectable Melanoma. J Immunother 2026 Apr 16. doi: 10.1097/CJI.0000000000000605.
PMID: 41983687